Gapping up
In reaction to strong earnings/guidance: VDSI +14.9%, LOGI +14.8%, QRE +11.3%, AGEN +9.8%, FB +9.2%, TDY +9%, FTNT +8.6%, SKX +8.4%, NOK +8.2%, UA +5.6%, EGHT +5.5%, HBI +5.2%, COG +4.7%, ORLY +4.4%, RJF +4%, PTEN +3.9%, ILMN +3.5%, JBLU +3.3%, NVEC +2.9%, POT +2.9%, INFN +2.8%, CRI +2.8%, UAL +2.2%, UAL +2.2%, FFIV +2%, IMAX+1.9%, SQNS +1.8%, MMM +1.8%, BMY +1.6%, HOT +1.5%, CAM +1.5%, CTXS +1.3%, ABC +1.3%, GILD +1.1%, NURO +1%.
M&A news: QRE +11.3% (to be acquired by Breitburn Energy Partners (BBEP)), ARIA +7.1% (attributed to a positive tweet that has since been deleted; Tweet was with regards to a SHPG for ARIA rumor).
Other news: APP +8.3% (disclosed details of new Board of Directors), DARA +8.1% (cont momentum), SPNC +7.4% (announces FDA clearance of peripheral laser atherectomy devices for in-stent restenosis ), TWTR +4.1% (following FB results), JMBA +3.8% (Engaged Capital disclosed 7.0% stake in SC 13D filing; believe the Issuer possesses multiple paths to value creation, expects to continue to have discussions with the Issuer's management), KNDI +2% (following yesterday's 12% decline), P +2% (following FB results), LNKD +1.3% (following FB results), FEYE +0.9% (on FTNT results), LL +0.9% (responded to lawsuit allegations, stating, "The allegations in this lawsuit concerning our product are simply flat-out false")
Analyst comments: WIBC +3.4% (upgraded to Strong Buy from Outperform at Raymond James), RKUS +2.6% (added to Conviction Buy list at Goldman), UIS +1.4% (upgraded to Positive from Neutral at Susquehanna), ZFGN +0.6% (initiated with a Outperform at Leerink Partners)
In reaction to strong earnings/guidance: VDSI +14.9%, LOGI +14.8%, QRE +11.3%, AGEN +9.8%, FB +9.2%, TDY +9%, FTNT +8.6%, SKX +8.4%, NOK +8.2%, UA +5.6%, EGHT +5.5%, HBI +5.2%, COG +4.7%, ORLY +4.4%, RJF +4%, PTEN +3.9%, ILMN +3.5%, JBLU +3.3%, NVEC +2.9%, POT +2.9%, INFN +2.8%, CRI +2.8%, UAL +2.2%, UAL +2.2%, FFIV +2%, IMAX+1.9%, SQNS +1.8%, MMM +1.8%, BMY +1.6%, HOT +1.5%, CAM +1.5%, CTXS +1.3%, ABC +1.3%, GILD +1.1%, NURO +1%.
M&A news: QRE +11.3% (to be acquired by Breitburn Energy Partners (BBEP)), ARIA +7.1% (attributed to a positive tweet that has since been deleted; Tweet was with regards to a SHPG for ARIA rumor).
Other news: APP +8.3% (disclosed details of new Board of Directors), DARA +8.1% (cont momentum), SPNC +7.4% (announces FDA clearance of peripheral laser atherectomy devices for in-stent restenosis ), TWTR +4.1% (following FB results), JMBA +3.8% (Engaged Capital disclosed 7.0% stake in SC 13D filing; believe the Issuer possesses multiple paths to value creation, expects to continue to have discussions with the Issuer's management), KNDI +2% (following yesterday's 12% decline), P +2% (following FB results), LNKD +1.3% (following FB results), FEYE +0.9% (on FTNT results), LL +0.9% (responded to lawsuit allegations, stating, "The allegations in this lawsuit concerning our product are simply flat-out false")
Analyst comments: WIBC +3.4% (upgraded to Strong Buy from Outperform at Raymond James), RKUS +2.6% (added to Conviction Buy list at Goldman), UIS +1.4% (upgraded to Positive from Neutral at Susquehanna), ZFGN +0.6% (initiated with a Outperform at Leerink Partners)